| | | | | | | | | | | | | | | | | | | | | | |
Ownership Document
|
| Schema Version: X0306 |
| Document Type: 4 |
| Period of Report: 9/19/22 |
| Not Subject to Section 16: 0 |
| Issuer: |
| Issuer CIK: 1501756 |
| Issuer Name: Adverum Biotechnologies, Inc. |
| Issuer Trading Symbol: ADVM |
| Reporting Owner: |
| Reporting Owner ID: |
| | Owner CIK: 1908942 |
| | Owner Name: Beckman Richard |
| Reporting Owner Address: |
| | Owner Street 1: C/O ADVERUM BIOTECHNOLOGIES, INC. |
| | Owner Street 2: 100 CARDINAL WAY |
| | Owner City: REDWOOD CITY |
| | Owner State: CA |
| | Owner ZIP Code: 94063 |
| | Owner State Description: |
| Reporting Owner Relationship: |
| | Is Director? No |
| | Is Officer? Yes |
| | Is Ten Percent Owner? No |
| | Is Other? No |
| | Officer Title: Chief Medical Officer |
| Non-Derivative Table: |
| Non-Derivative Transaction: |
| | Security Title: |
| | | Value: Common Stock |
| | Transaction Date: |
| | | Value: 9/19/22 |
| | Deemed Execution Date: |
| | Transaction Coding: |
| | | Transaction Form Type: 4 |
| | | Transaction Code: S |
| | | Equity Swap Involved? No |
| | | Footnote ID: F1 |
| | | Footnote ID: F2 |
| | Transaction Timeliness: |
| | | Value: |
| | Transaction Amounts: |
| | | Transaction Shares: |
| Value: 4,272 |
| | | Transaction Price Per Share: |
| Value: 1.0697 |
| Footnote ID: F3 |
| | | Transaction Acquired-Disposed Code: |
| Value: D |
| | Post-Transaction Amounts: |
| | | Shares Owned Following Transaction: |
| Value: 39,061 |
| | Ownership Nature: |
| | | Direct or Indirect Ownership: |
| Value: D |
| Footnotes: |
| Footnote - F1: The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units. |
| Footnote - F2: The reporting person's sale of Adverum common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of the same number of shares of Adverum common stock at a price of $0.8228 per share on May 17, 2022. The reporting person has paid to Adverum $1,055.01, representing the full amount of the profit realized in connection with the short-swing transaction. |
| Footnote - F3: Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.0721. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| Remarks: |
| Owner Signature: |
| Signature Name: Richard Beckman by /s/ Ron A. Metzger, Attorney-in-Fact |
| Signature Date: 9/21/22 |
